Stay updated on Avelumab-cetuximab-radiotx vs SOCs in LA SCCHN Clinical Trial
Sign up to get notified when there's something new on the Avelumab-cetuximab-radiotx vs SOCs in LA SCCHN Clinical Trial page.

Latest updates to the Avelumab-cetuximab-radiotx vs SOCs in LA SCCHN Clinical Trial page
- ChecktodayChange DetectedThe footer’s site revision label changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoChange DetectedThe ClinicalTrials.gov page now displays the REACH Phase 3 study record for avelumab, cetuximab, and radiotherapy versus standards of care for locally advanced head and neck cancer. It includes study design, participant criteria, locations, recruitment status, and measured outcomes.SummaryDifference54%

- Check14 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check28 days agoChange DetectedA site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” was added, and the site revision changed from v3.7.1 to v3.7.2. The study page still displays a 403 error.SummaryDifference1%

- Check42 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check56 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the usual study details with an access restriction; as a result, the record cannot be viewed.SummaryDifference19%

Stay in the know with updates to Avelumab-cetuximab-radiotx vs SOCs in LA SCCHN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab-cetuximab-radiotx vs SOCs in LA SCCHN Clinical Trial page.